| 1 |
35618039 | Adenosine kinase (ADK) inhibition with ABT-702 induces ADK protein degradation and a distinct form of sustained cardioprotection. | 2022 Jul 15 |
7 |
| 2 |
30910669 | Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction. | 2019 May |
1 |
| 3 |
24841126 | Adenosine kinase inhibition protects the kidney against streptozotocin-induced diabetes through anti-inflammatory and anti-oxidant mechanisms. | 2014 Jul |
1 |
| 4 |
21846498 | Adenosine kinase inhibition in the cochlea delays the onset of age-related hearing loss. | 2011 Nov |
3 |
| 5 |
11082453 | ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse. | 2000 Dec |
4 |